It was further observed that both CREB1 and GLUT1 expression levels were significantly elevated in GBM compared to normal brain and WHO grade I, II and III glioma samples, with CREB1 positively influencing the transcriptional activity of GLUT1, thereby enhancing its expression [45]. Here, CREB1 is linked to central nervous system cancer.